Samsung Biologics is one of the world's largest contract development and manufacturing organizations (CDMO) for biopharmaceuticals. Headquartered in Incheon, South Korea, the company operates the world's largest biomanufacturing capacity and serves global pharmaceutical clients including major Western pharma companies. Samsung Biologics is expanding into biosimilar development and cell & gene therapy manufacturing, positioning itself at the forefront of APAC's biotech manufacturing ecosystem.
三星生物制剂是全球最大的生物制剂合同开发和制造组织(CDMO),在全球制药供应链中发挥关键作用。
China's largest global biotech company focused on innovative oncology medicines
India's largest biopharmaceutical company and global biosimilars leader
South Korea's leading biosimilar manufacturer challenging global pharma giants
Japanese pharmaceutical giant leading in antibody-drug conjugates (ADCs)
Southeast Asia's leading omnichannel healthcare platform
Indonesia's leading telehealth and health-tech platform
当该公司有新信号时,立即收到通知。